Latest stories on INTS
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire56 · neutralgeneral
Gaush Meditech Profit Slumps on Softer Revenue as R&D Intensity Remains High
TipRanks38 · neutralearnings
NEOS’s ‘Boosted’ S&P Fund Pays 17% While the Nasdaq Version Pays 21%
Yahoo Top50 · neutralgeneral
Intensity Therapeutics price target raised to $7 from $5 at H.C. Wainwright
The Fly63 · neutralanalyst
Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research
PR Newswire63 · neutralproduct/pr
Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Intensity Therapeutics Price Target Lowered To 15 From 30 At Alliance Global
The Fly34 · bearishanalyst
Intensity therapeutics targets INVINCIBLE-4 enrollment completion by end of 2027 while seeking $30M to finish INVINCIBLE-3
Seeking Alpha53 · neutralgeneral
Intensity Therapeutics, Inc. (INTS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
INTENSITY THERAPEUTICS, INC. (INTS) files 8-K
SEC 8-K50 · neutralgeneral
Intensity Therapeutics Reports Q2 Eps 1 11 Consensus 77c
The Fly63 · neutralearnings
Intensity Therapeutics GAAP EPS of -$1.11 misses by $0.14
Seeking Alpha34 · bearishearnings
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire53 · neutralearnings
Italy’s Largest Bank Dumps BTC ETF for Staked Ethereum ETF
Yahoo Top38 · neutralgeneral
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
PR Newswire50 · neutralgeneral
NovaRed Mining Identifies Large High-Intensity Magnetic Target Associated with Regional Copper-Gold Intrusive System
StockTitan63 · neutralproduct/pr
Intensity Therapeutics Stockholders Approve Proposals at Annual Meeting
TipRanks50 · neutralgeneral
INTENSITY THERAPEUTICS, INC. (INTS) files 8-K
SEC 8-K50 · neutralgeneral
Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
PR Newswire65 · bullishgeneral
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire50 · neutralearnings